妊娠期呼吸道合胞病毒疫苗接种——欧洲委员会和妇产科学院（EBCOG）的立场声明

IF 2.1 4区医学 Q2 OBSTETRICS & GYNECOLOGY

European journal of obstetrics, gynecology, and reproductive biology Pub Date : 2025-04-17 DOI:10.1016/j.ejogrb.2025.113978

Diana Ramasauskaite , Charles Savona-Ventura , Meile Minkauskiene , Tahir Mahmood

{"title":"妊娠期呼吸道合胞病毒疫苗接种——欧洲委员会和妇产科学院（EBCOG）的立场声明","authors":"Diana Ramasauskaite , Charles Savona-Ventura , Meile Minkauskiene , Tahir Mahmood","doi":"10.1016/j.ejogrb.2025.113978","DOIUrl":null,"url":null,"abstract":"<div><div>The European Board and College of Obstetrics and Gynaecology (EBCOG) expresses its concerns on the morbidity associated with respiratory syncytial virus (RSV) infections in pregnant women and their infants. This position statement reviews the role of maternal vaccination against RSV during the third trimester of pregnancy to reduce the morbidity of RSV in both mother and child. The EBCOG Standing Committee on Standards of Care and Position Statements endorses the recommendation for the administration of 120 μg of a bivalent RSV prefusion F protein–based (RSVpreF) vaccine to pregnant women early in the third trimester. This provides protection against RSV and its attendant comorbidities both to the mother and the infant. Repeat RSV vaccination in subsequent pregnancies is not recommended due to lack of data. regular targeted vaccination of pregnant women.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"310 ","pages":"Article 113978"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Respiratory syncytial virus vaccination in pregnancy – Position statement by the European board and college of obstetrics and gynaecology (EBCOG)\",\"authors\":\"Diana Ramasauskaite , Charles Savona-Ventura , Meile Minkauskiene , Tahir Mahmood\",\"doi\":\"10.1016/j.ejogrb.2025.113978\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The European Board and College of Obstetrics and Gynaecology (EBCOG) expresses its concerns on the morbidity associated with respiratory syncytial virus (RSV) infections in pregnant women and their infants. This position statement reviews the role of maternal vaccination against RSV during the third trimester of pregnancy to reduce the morbidity of RSV in both mother and child. The EBCOG Standing Committee on Standards of Care and Position Statements endorses the recommendation for the administration of 120 μg of a bivalent RSV prefusion F protein–based (RSVpreF) vaccine to pregnant women early in the third trimester. This provides protection against RSV and its attendant comorbidities both to the mother and the infant. Repeat RSV vaccination in subsequent pregnancies is not recommended due to lack of data. regular targeted vaccination of pregnant women.</div></div>\",\"PeriodicalId\":11975,\"journal\":{\"name\":\"European journal of obstetrics, gynecology, and reproductive biology\",\"volume\":\"310 \",\"pages\":\"Article 113978\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-04-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of obstetrics, gynecology, and reproductive biology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0301211525002477\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of obstetrics, gynecology, and reproductive biology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0301211525002477","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

欧洲委员会和妇产科学院对孕妇及其婴儿与呼吸道合胞病毒（RSV）感染相关的发病率表示关切。本立场声明回顾了在妊娠晚期接种抗RSV疫苗以降低母亲和儿童RSV发病率的作用。EBCOG护理标准和立场声明常设委员会赞同在妊娠晚期早期给孕妇注射120 μg的基于RSV预融合F蛋白的二价疫苗（RSVpreF）。这为母亲和婴儿提供了防止呼吸道合并症及其伴随的合并症的保护。由于缺乏数据，不建议在随后的怀孕中重复接种RSV疫苗。定期有针对性地为孕妇接种疫苗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Respiratory syncytial virus vaccination in pregnancy – Position statement by the European board and college of obstetrics and gynaecology (EBCOG)

The European Board and College of Obstetrics and Gynaecology (EBCOG) expresses its concerns on the morbidity associated with respiratory syncytial virus (RSV) infections in pregnant women and their infants. This position statement reviews the role of maternal vaccination against RSV during the third trimester of pregnancy to reduce the morbidity of RSV in both mother and child. The EBCOG Standing Committee on Standards of Care and Position Statements endorses the recommendation for the administration of 120 μg of a bivalent RSV prefusion F protein–based (RSVpreF) vaccine to pregnant women early in the third trimester. This provides protection against RSV and its attendant comorbidities both to the mother and the infant. Repeat RSV vaccination in subsequent pregnancies is not recommended due to lack of data. regular targeted vaccination of pregnant women.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European journal of obstetrics, gynecology, and reproductive biology 医学-妇产科学

CiteScore

4.60

自引率

3.80%

发文量

898

审稿时长

8.3 weeks

期刊介绍： The European Journal of Obstetrics & Gynecology and Reproductive Biology is the leading general clinical journal covering the continent. It publishes peer reviewed original research articles, as well as a wide range of news, book reviews, biographical, historical and educational articles and a lively correspondence section. Fields covered include obstetrics, prenatal diagnosis, maternal-fetal medicine, perinatology, general gynecology, gynecologic oncology, uro-gynecology, reproductive medicine, infertility, reproductive endocrinology, sexual medicine and reproductive ethics. The European Journal of Obstetrics & Gynecology and Reproductive Biology provides a forum for scientific and clinical professional communication in obstetrics and gynecology throughout Europe and the world.